US Code

Search

Search the current U.S. Code within Title 21

Search by citation or keyword across the current edition within Title 21.

20 results 505
Scoped to Title 21
Title 21 Title 21 / Section 355b

21 U.S.C. § 355b

Adverse-event reporting

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Adverse-event reporting

Title 21 Title 21 / Section 875

21 U.S.C. § 875

Administrative hearings

Subchapter I CONTROL AND ENFORCEMENT / Part E Administrative and Enforcement Provisions

Administrative hearings

Title 21 Title 21 / Section 393a

21 U.S.C. § 393a

Office of Pediatric Therapeutics

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter X MISCELLANEOUS

Office of Pediatric Therapeutics

Title 21 Title 21 / Section 962

21 U.S.C. § 962

Second or subsequent offenses

Chapter 13 DRUG ABUSE PREVENTION AND CONTROL / Subchapter II IMPORT AND EXPORT

Second or subsequent offenses

Title 21 Title 21 / Section 355c–1

21 U.S.C. § 355c–1

Report

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Report

Title 21 Title 21 / Section 355d

21 U.S.C. § 355d

Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers

Title 21 Title 21 / Section 360a–1

21 U.S.C. § 360a–1

Clinical trials

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Clinical trials

Title 21 Title 21 / Section 360n–1

21 U.S.C. § 360n–1

Priority review for qualified infectious disease products

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Priority review for qualified infectious disease products

Title 21 Title 21 / Section 825

21 U.S.C. § 825

Labeling and packaging

Subchapter I CONTROL AND ENFORCEMENT / Part C Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances

Labeling and packaging

Title 21 Title 21 / Section 355e

21 U.S.C. § 355e

Pharmaceutical security

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Pharmaceutical security

Title 21 Title 21 / Section 355g

21 U.S.C. § 355g

Utilizing real world evidence

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Utilizing real world evidence

Title 21 Title 21 / Section 321

21 U.S.C. § 321

Definitions; generally

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter II DEFINITIONS

Definitions; generally

Title 21 Title 21 / Section 301

21 U.S.C. § 301

Short title

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter I SHORT TITLE

Short title

Title 21 Title 21 / Section 331

21 U.S.C. § 331

Prohibited acts

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter III PROHIBITED ACTS AND PENALTIES

Prohibited acts

Title 21 Title 21 / Section 374

21 U.S.C. § 374

Inspection

Subchapter VII GENERAL AUTHORITY / Part A General Administrative Provisions

Inspection

Title 21 Title 21 / Section 360ddd

21 U.S.C. § 360ddd

Definitions

Subchapter V DRUGS AND DEVICES / Part G Medical Gases

Definitions

Title 21 Title 21 / Section 355a

21 U.S.C. § 355a

Pediatric studies of drugs

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Pediatric studies of drugs

Title 21 Title 21 / Section 355c

21 U.S.C. § 355c

Research into pediatric uses for drugs and biological products

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Research into pediatric uses for drugs and biological products

Title 21 Title 21 / Section 355

21 U.S.C. § 355

New drugs

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

New drugs

Title 21 Title 21 / Section 355–1

21 U.S.C. § 355–1

Risk evaluation and mitigation strategies

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Risk evaluation and mitigation strategies